Home Cart 0 Sign in  
X

[ CAS No. 3314-30-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 3314-30-5
Chemical Structure| 3314-30-5
Chemical Structure| 3314-30-5
Structure of 3314-30-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 3314-30-5 ]

Related Doc. of [ 3314-30-5 ]

Alternatived Products of [ 3314-30-5 ]

Product Details of [ 3314-30-5 ]

CAS No. :3314-30-5 MDL No. :MFCD00228045
Formula : C8H6N2O Boiling Point : -
Linear Structure Formula :- InChI Key :DQOSJWYZDQIMGM-UHFFFAOYSA-N
M.W : 146.15 Pubchem ID :76826
Synonyms :

Calculated chemistry of [ 3314-30-5 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 41.48
TPSA : 45.75 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.45 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.35
Log Po/w (XLOGP3) : 1.05
Log Po/w (WLOGP) : 1.38
Log Po/w (MLOGP) : 0.35
Log Po/w (SILICOS-IT) : 2.17
Consensus Log Po/w : 1.06

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.95
Solubility : 1.65 mg/ml ; 0.0113 mol/l
Class : Very soluble
Log S (Ali) : -1.6
Solubility : 3.66 mg/ml ; 0.025 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.84
Solubility : 0.213 mg/ml ; 0.00146 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.13

Safety of [ 3314-30-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 3314-30-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 3314-30-5 ]
  • Downstream synthetic route of [ 3314-30-5 ]

[ 3314-30-5 ] Synthesis Path-Upstream   1~7

  • 1
  • [ 5466-57-9 ]
  • [ 3314-30-5 ]
YieldReaction ConditionsOperation in experiment
85.3% With sulfuric acid In water at 80℃; for 1 h; 15 mL (276 mmol, 6.6 eq) of concentrated sulfuric acid was slowly added dropwise to 8.40 g (41.8 mmol) of compound L5, Yellow bubbles, 10min after the drop is completed, At this time compound L5 is completely dissolved, The oil bath was heated at 80 ° C for 1 h and the reaction was stopped. Cold to room temperature, Add 150mL ice water, 4N NaOH aqueous solution adjusted to pH 7, At this time the original transparent solution in the precipitation of yellow solid, Filter, drying, Get 5.21g, The yield was 85.3percent. To give 1H-benzimidazole-2-formaldehyde,Compound code L6.
Reference: [1] Patent: CN104211632, 2016, B, . Location in patent: Paragraph 0131; 0132
[2] Pharmazie, 1980, vol. 35, # 10, p. 585 - 586
  • 2
  • [ 95-54-5 ]
  • [ 298-12-4 ]
  • [ 3314-30-5 ]
YieldReaction ConditionsOperation in experiment
81% With hydroxyapatite In water at 52℃; for 6 h; 200 mesh hydroxyapatite powder, 0.008g as catalystUse 52 mL of hot water as solvent,The reaction was carried out with 0.1 mol o-phenylenediamine and 0.11 mol glyoxylic acid as raw materials. The reaction time was 6 hours and the reaction temperature was 52°C.After the reaction is over,Hot filter,Cool the filtrate to 2 °CWhite crystals precipitated,Filtered to obtain crystals,35 °C vacuum drying overnight,That is, benzimidazole-2-formaldehyde 11.9g, yield 81percent,Purity 99.6percent,
Reference: [1] Patent: CN105198819, 2017, B, . Location in patent: Paragraph 0014-0016; 0017-0018; 0019-0020
  • 3
  • [ 4856-97-7 ]
  • [ 3314-30-5 ]
YieldReaction ConditionsOperation in experiment
70% With [Ru(2,6-bis[1-(pyridin-2-yl)-1H-benzo[d]-imidazol-2-yl]pyridine)(pyridine-2,6-dicarboxylate)]; dihydrogen peroxide In water at 50℃; for 5.5 h; The procedure for gram scale oxidation of (1H-benzo[d]imidazol-2-yl)methanol to 1H-benzo[d]imidazole-2-carbaldehydewas as follows: (1H-benzo[d]imidazol-2-yl)methanol (0.1 mol,14.8 g) and [Ru(bpbp)(pydic)] (0.001 mmol, 7.32 × 10−3 g) wereadded into a reactor. The reactor containing this mixture was heatedto 50 °C in an oil bath under vigorous stirring and then 30percent H2O2(30 mL, 0.3 mol) was slowly dropwise over a period of 30 min. The mixture was stirred for 5 h. After filtering, the solution wasevaporation under reduced pressure at 50 °C. Pure 1H-benzo[d]imidazole-2-carbaldehyde (0.07 mmol, 10.2 g) was obtained with ayield of 70percent after recrystallisation from 30percent H2SO4 solution. Theproduct, 1H-benzo[d]imidazole-2-carbaldehyde, was identified byits 1H NMR spectrum.
57% at 50℃; The method for synthesizing 2-aldehyde benzimidazole in this example is as follows2-Hydroxymethylbenzimidazole (0.1 mol, 14.8 g)The rhodium complex (10-4 mol, 0.0577 g) in Example 1 was added to the reaction vessel.Hydrogen peroxide (30percent, 0.3 mol, 9.1 ml) was slowly added to the reaction vessel with stirring.The reaction temperature was controlled at 50°C for several hours.The reaction solution was concentrated under reduced pressure,Obtain a solid product,The solid product was dissolved in dichloromethane and subjected to silica gel column chromatography.Get pure product2-aldehyde benzoimidazole 8.32 g,Yield 57percent.
51% With manganese(IV) oxide In methanol; dichloromethane General procedure: To a stirred solution of the (1H-benzo[d]imidazol-2-yl)methanol from above (2.6 mmol) in dryCH2Cl2/MeOH (6:1, 3.5 mL) was added activated manganese dioxide (85percent purity, <5 micron, 2.328 g, 22.8 mmol)and the suspension stirred overnight, at which point the black slurry was filtered through a cake of celite andwashed with MeOH (3x5 mL). The combined washings were concentrated to afford a dark brown solid.Purification of the crude product by column chromatography on silica gel (CH2Cl2:MeOH, 98:2 to 95:5) affordedthe title compound 1H-benzo[d]imidazole-2-carbaldehyde (2i) (0.245 g, 51percent).
Reference: [1] Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2003, vol. 42, # 12, p. 3128 - 3130
[2] Journal of Fluorescence, 2011, vol. 21, # 5, p. 2005 - 2013
[3] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1982, # 12, p. 2871 - 2876
[4] Angewandte Chemie - International Edition, 1998, vol. 37, # 9, p. 1270 - 1273
[5] Journal of Chemical Research, 2017, vol. 41, # 2, p. 88 - 92
[6] Canadian Journal of Chemistry, 2003, vol. 81, # 6, p. 612 - 619
[7] Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2003, vol. 42, # 7, p. 1765 - 1767
[8] Patent: CN107445998, 2017, A, . Location in patent: Paragraph 0028-0031
[9] Synthesis (Germany), 2015, vol. 47, # 13, p. 1913 - 1921
[10] Journal of Medicinal and Pharmaceutical Chemistry, 1959, vol. 1, p. 577,594
[11] Molecules, 2016, vol. 21, # 11,
[12] Patent: CN107118249, 2017, A, . Location in patent: Paragraph 0120; 0121; 0122
[13] Patent: US5610299, 1997, A,
  • 4
  • [ 95-54-5 ]
  • [ 3314-30-5 ]
Reference: [1] Chemische Berichte, 1956, vol. 89, p. 689,691
[2] Angewandte Chemie, 1956, vol. 68, p. 151
[3] Patent: DE942327, 1953, ,
[4] Synthesis (Germany), 2015, vol. 47, # 13, p. 1913 - 1921
[5] Molecules, 2016, vol. 21, # 11,
[6] Patent: CN104211632, 2016, B,
[7] Patent: CN107118249, 2017, A,
  • 5
  • [ 615-15-6 ]
  • [ 3314-30-5 ]
Reference: [1] Journal of the Indian Chemical Society, 1982, vol. 59, # 3, p. 349 - 351
[2] Wiss. Z. Univ. Halle-Wittenberg, 1959, vol. 8, p. 1037
[3] Journal of Medicinal and Pharmaceutical Chemistry, 1959, vol. 1, p. 577,594
  • 6
  • [ 13109-82-5 ]
  • [ 3314-30-5 ]
Reference: [1] Patent: DE942327, 1953, ,
[2] Chemische Berichte, 1956, vol. 89, p. 689,691
  • 7
  • [ 5466-57-9 ]
  • [ 144-62-7 ]
  • [ 3314-30-5 ]
Reference: [1] Angewandte Chemie, 1956, vol. 68, p. 151
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 3314-30-5 ]

Aldehydes

Chemical Structure| 3012-80-4

[ 3012-80-4 ]

1-Methyl-1H-benzo[d]imidazole-2-carbaldehyde

Similarity: 0.93

Chemical Structure| 885280-34-2

[ 885280-34-2 ]

6-Fluoro-1H-benzo[d]imidazole-2-carbaldehyde

Similarity: 0.84

Chemical Structure| 4597-21-1

[ 4597-21-1 ]

1,2-Dimethyl-1H-benzo[d]imidazole-5-carbaldehyde

Similarity: 0.74

Chemical Structure| 68282-52-0

[ 68282-52-0 ]

2,4-Dimethyl-1H-imidazole-5-carbaldehyde

Similarity: 0.66

Chemical Structure| 56248-10-3

[ 56248-10-3 ]

5-Phenyl-1H-imidazole-2-carbaldehyde

Similarity: 0.63

Related Parent Nucleus of
[ 3314-30-5 ]

Benzimidazoles

Chemical Structure| 3012-80-4

[ 3012-80-4 ]

1-Methyl-1H-benzo[d]imidazole-2-carbaldehyde

Similarity: 0.93

Chemical Structure| 939-70-8

[ 939-70-8 ]

1-(1H-Benzo[d]imidazol-2-yl)ethanone

Similarity: 0.89

Chemical Structure| 615-15-6

[ 615-15-6 ]

2-Methyl-1H-benzo[d]imidazole

Similarity: 0.88

Chemical Structure| 29043-48-9

[ 29043-48-9 ]

2-Methyl-1H-benzoimidazol-5-ylamine

Similarity: 0.86

Chemical Structure| 1571-93-3

[ 1571-93-3 ]

2-Methyl-1H-benzo[d]imidazol-5-amine hydrochloride

Similarity: 0.85